Medasense Biometrics Ltd. Raises $8 Million Investment in Series B Financing Accelerating the Commercialization of Objective Pain Monitoring Medasense Biometrics Ltd., developer of a proprietary objective pain monitoring technology, announced…
Medasense Biometrics to Present at the MassMEDIC MedTech Conference on Friday, November 7th in Boston, USA.
Results of a Study Measuring Pain in Patients Undergoing Spinal Cord Stimulation Treatments were Presented at the 2014 International Association of Pain, 6-11th October 2014, in Buenos Aires, Argentina.
Capital Point invests in Medasense Biometrics
Medasense to present at Personalized Medicine World Conference 2010 Israel
Results of Medasense supported research were presented on the annual conference of the Israel Pain Association
OHV and Dr. Shmuel Cabilly invest in Medasense Biometrics
Medasense to present at ILSI- Biomed Israel 2011 (Monday, May 23, 18:10 – 18:30)
Medasense Biometrics has appeared on “The Landes Shortlist of Promising Israeli Technologies”, by C. Wylie, Cell Cycle, Vol. 10, pp. 1887-1881
Medasense Biometrics technology is featured in a newspaper article “Feel its pain: why the healthcare system doesn’t have a standard for measuring pain?” by Gali Weinreb, Globes, August 27th, 2011…